The FDA today announced a virtual public meeting to discuss patient-generated health data (PGHD) and its potential impact across the healthcare ecosystem.
Health and treatment history, biometric data, symptoms, and lifestyle habits can all be categorized as PGHD. Sources of PGHD, data quality measures, interoperability and potential impacts of the data in regulatory and healthcare settings will be discussed during the meeting, scheduled for 10 a.m. to 4 p.m. Eastern time May 4.
Get the full story on our sister site, Medical Design & Outsourcing.